Journal History

2013 The journal releases the inaugural issue and is published as a quarterly journal under the direction of the founding Editor-in-Chief, Prof. Dr. Kenneth Cornetta.
2015 Biomedicines establishes the following section:
Tumor Immunology and Immunotherapy (later was renamed as Immunology and Immunotherapy).
2016 Biomedicines is covered by Emerging Sources Citation Index (ESCI) of the Web of Science.
Biomedicines establishes the following section:
Neurologic Disease (later was renamed as Neurobiology and Neurologic Disease).
2017 Biomedicines is covered by two important databases: PubMed and Scopus.
Biomedicines starts the Travel Awards project.
2018 Biomedicines establishes the following section:
Natural compounds in Biomedicine (later was renamed as Drug Discovery and Development).
2019 Biomedicines is covered by the Science Citation Index Expanded (SCIE).
Biomedicines establishes the following 7 sections:
Cancer Therapeutics (later was renamed as Cancer Biology and Therapeutics)
Nanotechnology and Biotechnology (later was renamed as Biomedical Materials and Nanomedicine)
Therapeutic Strategies in Different Diseases (later was renamed as Molecular and Translational Medicine)
Gene and Cell Therapy
Thrombosis and Hemostasis (discontinued later)
Model Systems in Research and Development (discontinued later)
Virology, Vaccines and Viral Vectors (discontinued later)
Tumor Cell Biology (discontinued later).
2020 Biomedicines adopts a monthly publication schedule.
Biomedicines receives its first impact factor: 4.717. The journal ranks 30th out of 138 (Q1) titles in the 'Medicine, Research & Experimental' category, as well as 36th out of 270 (Q1) titles in 'Pharmacology & Pharmacy'.
Biomedicines publishes its 1,000th paper.
Biomedicines rearranges the sections as following:
Immunology and Immunotherapy
Neurobiology and Neurologic Disease
Drug Discovery and Development
Cancer Biology and Therapeutics
Gene and Cell Therapy
Molecular and Translational Medicine
Biomedical Materials and Nanomedicine

Biomedicines starts the Young Investigator Award project.
Biomedicines organized the 1st International Electronic Conference on Biomedicine (ECB 2021).
Biomedicines organized the First Canadian Peptide and Protein Community Virtual Symposium (CPPC 2021).
Biomedicines received its 2020 impact factor (6.081).
Biomedicines established the following sections:
Cell Biology and Pathology
Endocrinology and Metabolism Research
Microbiology in Human Health and Disease
Molecular Genetics and Genetic Diseases
Section Biomedical Materials and Nanomedicine was divided into three sections: Nanomedicine and Nanobiology and Biomedical Materials and Biomedical Engineering in Human Health
Section Drug Discovery and Development was divided into four sections: Pharmacogenomic and Personalized Medicines and Drug Discovery and Drug Metabolism and Drug Delivery

2022 The year 2022 marked the 10th Anniversary of Biomedicines.
Biomedicines announced 2022 Best Paper Award for Anniversary Special Issues, 2022 Early-Career Women Award and 2022 Young Investigator Award.


2013–2016 Founding Editor-in-Chief: Prof. Dr. Kenneth Cornetta
2016–present Editor-in-Chief: Prof. Dr. Shaker A. Mousa

Section Editor-in-Chief

2016–2022 Section Editor-in-Chief: Dr. Vincenzo Cerullo for the Section on Tumor Immunology and Immunotherapy
2016–present Section Editor-in-Chief: Dr. Bruno Meloni for the Section on Neurologic Disease
2019–present Section Editor-in-Chief: Prof. Dr. Jun Lu for the Section on Drug Discovery and Development
Section Editor-in-Chief: Dr. Veronique Baud for the Section on Cancer Therapeutics

Section Editor-in-Chief: Prof. Dr. Paul Rösch for the Section on Cell Biology and Pathology
Section Editor-in-Chief
: Prof. Dr. Robert Passier for the Section on Biomedical Engineering in Human Health
Section Editor-in-Chief
: Prof. Dr. Manfredi Tesauro for the Section on Endocrinology and Metabolism Research
Section Editor-in-Chief
: Dr. Bernard Lebleu for the Section on Gene and Cell Therapy

Back to TopTop